Carole advises emerging growth companies from formation to exit primarily in the biotech, medical device, diagnostic and healthcare technology sectors. She specializes in corporate law and governance, financing and M&A transactions and has considerable experience working with faculty members at research institutions across the country in the formation and financing of new companies. She also regularly represents investors in privately held companies in the life sciences.